Financial News
Stories about Aimmune Therap
Here's Why Aimmune Therapeutics Stock Jumped on Wednesday
October 02, 2019
From Motley Fool
AIMT Makes Bullish Cross Above Critical Moving Average
October 02, 2019
Tags
Stocks
From Market News Video
31 Stocks Moving In Wednesday's Mid-Day Session
October 02, 2019
From Benzinga
25 Healthcare Stocks Moving In Wednesday's Pre-Market Session
October 02, 2019
From Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
October 02, 2019
From Benzinga
The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
October 02, 2019
From Benzinga
First Week of AIMT November 15th Options Trading
September 25, 2019
Tags
Stocks
From Market News Video
Pick Up This Deal Even Lower Than Chief Financial Officer Bjerkholt Did
September 23, 2019
Tags
Stocks
From Market News Video
Will Vaping Deaths Derail Marijuana Stocks? Plus, a New Treatment for Peanut Allergies Advances
September 22, 2019
From Motley Fool
Analyst: DBV's Peanut Allergy Drug Could Outscore Aimmune's On Safety Front
September 16, 2019
From Benzinga
Profit-Takers Drag This Highflying Biotech Stock Into The Red
September 16, 2019
A Look At Benzinga Pro's Most-Searched Tickers For September 16, 2019
September 16, 2019
From Benzinga
Shares of Aimmune Therapeu Are Down on Strong Volume (AIMT)
September 16, 2019
25 Stocks Moving in Monday's Pre-Market Session
September 16, 2019
From Benzinga
A Mixed FDA Panel Just Recommended This Biotech's Peanut Allergy Drug
September 13, 2019
Tags
companyNews
24 Stocks Moving in Friday's Pre-Market Session
September 13, 2019
From Benzinga
The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans
September 13, 2019
From Benzinga
28 Healthcare Stocks Moving In Thursday's Pre-Market Session
September 12, 2019
From Benzinga
71 Biggest Movers From Yesterday
September 12, 2019
From Benzinga
Did the FDA Just Signal Smooth Sailing Ahead For Aimmune Therapeutics?
September 11, 2019
From Motley Fool
Potential Peanut Allergy Treatment Gives Pharma Company A Boost
September 11, 2019
From ETF Trends
Notable Wednesday Option Activity: VIAV, AIMT, ACHC
September 11, 2019
Tags
Stocks
From Market News Video
Here's Why Aimmune Therapeutics Stock Is Surging Today
September 11, 2019
From Motley Fool
48 Stocks Moving In Wednesday's Mid-Day Session
September 11, 2019
From Benzinga
Why This Peanut Allergy-Focused Biotech Stock Rocketed In Huge Volume
September 11, 2019
Aimmune Therapeu Rising Today on Above-Average Volume (AIMT)
September 11, 2019
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.